1. Please verify spelling: the word "medication" is often used instead of "mediation." Also, "significant statistical" is used instead of statistically significant. Careful English language editing is needed. 2. It is confusing and unnecessary to divide the subtypes of SMM and it creates too many acronyms. Just define SMM as all of the indicators. They can be put in an appendix in a Table. 3. The other outcomes you report are of unclear clinical relevance or association with IVF (eg., HBV infection, iron deficiency anemia). They detract from the study and should be removed. 4. The range of deliveries at your centres (358 -9366) indicates that your population is very heterogeneous. Women who delivery at a centre that does only 300 deliveries certainly differ from those who deliver at a large urban centre. You should report SMM rates by centre. 5. You do not account for reason for treatment (eg. male factor, uterine, PCOS, etc), number of IVF attempts, or time to pregnancy which are known to be predictive of poor health outcomes 6. Martin and colleagues (Obstet Gynecol 2016) and Belanoff and colleagues (Obstet Gynecol 2016) both demonstrated a higher risk of SMM due to IVF in singletons in two separate US cohorts. While you reference these authors in your manuscript, you do not sufficiently explain how your study/cohort might be different from theirs, except for the slightly different SMM definition. In fact the SMM definition they used is quite similar to yours and cannot be the sole reason they found a two-fold effect due to IVF in singletons. Further exploration is warranted. 7. I am not an expert in mediation modeling and suggest review by a biostatistician. I would suggest to add a power calculation -with the number of IVF multiples/event rates in your cohort, do you think your study has adequate power to demonstrate a real mediating effect? What is the uncertainty in your result?
REVIEWER
Erica Wang Cedars-Sinai Medical Center, United States REVIEW RETURNED 01-May-2018
GENERAL COMMENTS
1. Please provide more detail in terms of how you identified mode of conception. Did the investigators ask each patient or did each patient fill out a questionnaire? The methods section states that mode of conception was "confirmed by clinicians according to medical records and other relevant materials". Did clinicians review the charts of all 22,368 women? Although the study includes only IVF and spontaneous conceptions, NIFT conceptions also had to be identified in order to be excluded. The flow diagram demonstrates that there were only 6 NIFT conceptions in the cohort, about 0.02%, which seems highly unlikely. Can the authors provide information on the number of IVF cycles and subsequent live births that occur in their geographical region to lend substance to their classification methods?
2. The authors identified >3% SMM cases due to a broad definition that includes PLTCs, MNMs, and CTIs. Some may be of the opinion that this definition is too non-specific. Please provide a subgroup analysis excluding severe preeclampsia and blood transfusion as SMM events -this will allow for identification of of true SMM cases.
3. Please comment on how cesarean delivery plays a role in your analyses and whether cesarean delivery is a risk factor for SMM.
4. Table 5 should have a footnote that outlines the details of each model. The footnote should also include the confounding variables that are included in the models. The table should stand alone. In tine with this, the report of models 1-4 in the results section of the abstract is a little confusing.
5. Discussion -This reviewer disagrees that there are no guidelines on number of embryos to transfer. In the United States, ASRM has clear guidelines on the number of embryos to transfer. This reviewer agrees that there is variability in terms of whether clinics adhere to the guidelines. Could the authors please comment on the practice of eSET in their geographical region and whether there are guidelines in China for this practice?
1. As the authors point out, previous papers have focused on multiple gestations as an effect modifier between IVF and SMM. A strength of this paper is the mediation approach. However, the mediation analysis could be enriched. In particular, the authors use the Baron & Kenney (1986) method, which is a classic approach for mediation analysis and is appropriate if there is no exposure-mediator interaction. Additional analyses using modern approaches would be beneficial. For instance, it would be informative to assess what proportion of the total effect of IVF on SMM is due to multiple gestations using natural or controlled direct and indirect effect estimations; e.g. see any of the following references:
VanderWeele TJ. Epidemiology. 2010; 172: 1339 -1348 .
If the analysis cannot be expanded, then the assumptions of no exposure-mediator interaction and of complete adjustment for relevant confounding variables (see comment #2 below) should be explicitly stated; and a brief discussion should be added to the limitations discussing the consequences of violations to these assumptions.
2.
A directed acyclic graph (DAG) such as that below could also be helpful to include, with estimates of specific effects along the main pathways of interest to display the direct and indirect effect estimates. Even if such a graph is not included in the manuscript, it can be helpful to construct when thinking about what potential confounders need to be included. As 
3.
Model 4 (a subset on the singleton pregnancies) was included as a "supporting and exploratory analysis". Could you also include a model subset on multiple pregnancies evaluating the adjusted association between IVF and SMM among multiple pregnancies as a supporting and exploratory analysis? You do this for the unadjusted model; but not the adjusted model.
4.
In the conclusions, you note that "The results highlight the importance of transferring a limited number of embryos to reduce SMM". In a similar vein to the comments above, it would be helpful to expand the mediation analysis to yield results in clinically relevant and interpretable results -how many estimated SMM events would be avoided if IVF did not result in multiple gestations 
IVF

5.
Page 15, line 11: Among 22,368 eligible pregnancies extracted from medical charts and EMR database, was there really NO missing data on any of the variables you collected? That seems unlikely unless no missing data was part of the eligibility criteria. Please clarify.
Minor Comments
1. In the abstract, references to Model 1, Model 2, Model 3 and Model 4 are uninformative in that it is unclear what these labels imply for each model. A more descriptive explanation would be helpful. For instance, instead of "Model 1 showed that IVF was associated with …", say something like "In a model unadjusted for multiple gestations, IVF was associated with …".
2.
In the abstract conclusions, "the impact of IVF of SMM was mediated…" (not "medicated") 3. Page 5, line 6 -"transplant" should be "transfer" 4. Page 10, "SMM definition and measurement" section --There are so many acronyms in this section, it becomes confusing. It would be clearer for the reader if MNM, SMC, and CTI were replaced with "maternal near miss", "severe maternal complications" and "critical interventions", respectively. Similarly, on page 14 (second paragraph of results). Confidence intervals are the more informative measure here, and they are already being presented.
5.
9. Page 19, line 16: I wouldn't say that the interaction approach is "undesirable"; rather, it is a different approach that leads to different information. Just because multiple gestations is a consequence of IVF does not mean interaction analysis is not appropriate; indeed, one needs to consider whether there is exposure-mediator interaction in order to determine the appropriate mediation approach.
10. Page 19, line 30: This is strong language; "our analyses support this hypothesis" is more appropriate than "confirmed".
11. Page 21, line 40: The word "effect" should be changed to "association".
VERSION 1 -AUTHOR RESPONSE
Reviewers' Comments to Author:
Reviewer: 1 Comment #1 This is an interesting study on a topic of increasing public health importance. The authors performed a 6-centre retrospective study in China evaluating the mediating effect of multiple gestation on SMM risk due to IVF. Their conclusion is that the adverse effect of IVF on maternal health is mediated through multiple gestation. Their findings are interesting but a number of issues should be addressed before publication.
[Response] Thank you for your review and helpful comments.
Comment #2 Please verify spelling: the word "medication" is often used instead of "mediation." Also, "significant statistical" is used instead of statistically significant. Careful English language editing is needed.
[Response] We have carefully edited the language. Comment #3 It is confusing and unnecessary to divide the subtypes of SMM and it creates too many acronyms. Just define SMM as all of the indicators. They can be put in an appendix in a Table. [Response] Thank you for your suggestion. We have presented the indicators in Appendix 1. Comment #4 The other outcomes you report are of unclear clinical relevance or association with IVF (eg., HBV infection, iron deficiency anemia). They detract from the study and should be removed.
[Response] Sorry for the confusion. We actually treated the variables such as HBV infection and iron deficiency anemia as baseline characteristics, and included these variable in the adjusted analyses.
Comment #5 The range of deliveries at your centres (358 -9366) indicates that your population is very heterogeneous. Women who delivery at a centre that does only 300 deliveries certainly differ from those who deliver at a large urban centre. You should report SMM rates by centre.
[Response] We have reported the incidence of SMM by center. It now reads as below.
The incidences of SMM among six hospitals varied from 14.09/1000 to 51.57/1000. Comment #6 You do not account for reason for treatment (eg. male factor, uterine, PCOS, etc), number of IVF attempts, or time to pregnancy which are known to be predictive of poor health outcomes
[Response] Thank you for mentioning this. We recognized the limitation of our analysis. We did not account for these issues, primarily due to the fact that such data were difficult to collect and are usually unavailable from retrospective dataset. We have added this to the limitation of the discussion section. It now reads as below.
Although we attempted to include all potential confounders in our analysis, some -such as uterine status and male factor -were difficult to measure and unavailable in our dataset. In addition, we were unable to control for other unmeasured confounders.
Comment #7 Martin and colleagues (Obstet Gynecol 2016) and Belanoff and colleagues (Obstet Gynecol 2016) both demonstrated a higher risk of SMM due to IVF in singletons in two separate US cohorts. While you reference these authors in your manuscript, you do not sufficiently explain how your study/cohort might be different from theirs, except for the slightly different SMM definition. In fact the SMM definition they used is quite similar to yours and cannot be the sole reason they found a two-fold effect due to IVF in singletons. Further exploration is warranted.
[Response] We believe that the definition we used for SMM differed from those used in previous studies. In our study, we used the WHO approach, which included a broader spectrum of serious adverse events, such as severe postpartum hemorrhage, severe preeclampsia, laparotomy and admission to ICU. These four events, as a matter of fact, accounted for a large proportion of total events (77.2%) of total events in our data set.
Secondly, the definition of exposure may also be substantially different. In the two studies by Martin et al and Belanoff et al, they included a diversity of assisted reproductive technologies (ARTs), such as ovarian stimulation by drug treatments, intrauterine insemination (IUI), and IVF. The apparent effect may be a result of combined effects of multiple interventions. In comparison, our analysis focused on IVF.
Thirdly, the difference in results is partly because the adjustment for confounders among studies differed. Some important confounders, such as maternal IDA and HBV infection identified at the first antenatal visit, were included in our analysis but not in previous studies. Due to high prevalence of IDA and HBV infection in the Chinese population, adjustment for these two confounders may alter the association between IVF and risk of SMM findings.
We have revised our interpretation of findings in the discussion section, as below. Different with the three published studies in the U.S. which adopted the definition and criteria of SMM by 25 indicators using ICD-9 or ICD-10 codes, 12-14 Our study used the WHO approach8, which included a broader spectrum of serious adverse events, such as severe postpartum hemorrhage, severe preeclampsia, laparotomy and admission to ICU. These four events, as a matter of fact, accounted for a large proportion of total events (77.2%) of total events in our data set. In our study, the incidence of SMM was 34.69/1000 persons, as opposed to 11/1000 persons (about 1.1%). 12, 14
In addition, the definition of exposure may be substantially different. In the two studies by Martin et al and Belanoff et al, they included a diversity of assisted reproductive technologies (ARTs), such as ovarian stimulation by drug treatments, intrauterine insemination (IUI), and IVF. The apparent effect may be a result of combined effects of multiple interventions 12-14. In comparison, our analysis focused on IVF.
Furthermore, the difference in results is partly because the adjustment for confounders among studies differed. Some important confounders, such as maternal IDA and HBV infection identified at the first antenatal visit, were included in our analysis but not in previous studies. Due to high prevalence of IDA and HBV infection in the Chinese population34,35, adjustment for these two confounders may alter the association between IVF and SMM. Comment #8 I am not an expert in mediation modeling and suggest review by a biostatistician. I would suggest to add a power calculation -with the number of IVF multiples/event rates in your cohort, do you think your study has adequate power to demonstrate a real mediating effect? What is the uncertainty in your result?
[Response] Thank you. The third reviewer has undertaken the statistical review. Please see our response to the comments. In general, our analyses were conducted based on adequate power and we have slightly adjusted our statistical analyses according to the reviewer's comments.
Reviewer: 2 Comment #1 Please provide more detail in terms of how you identified mode of conception. Did the investigators ask each patient or did each patient fill out a questionnaire? The methods section states that mode of conception was "confirmed by clinicians according to medical records and other relevant materials". Did clinicians review the charts of all 22,368 women?
[Response] In the regular practice at the six hospitals, obstetricians used a pre-defined questionnaire to document the model of conception, together with other information, at the first antenatal visit (before 15 gestational weeks). The response options for the question about conception model included IVF-ET, IUI and others. Therefore, the data regarding conception model was retrospectively collected. It now reads as below.
In the regular practice at the six hospitals, obstetricians used a pre-defined questionnaire to document the model of conception, together with other information, at the first antenatal visit (before 15 gestational weeks). The response options for the question about conception model included IVF-ET, IUI and others. The pregnant women with IVF during this pregnancy were treated as exposure and the pregnant women with spontaneous conception as control.
Comment #2 Although the study includes only IVF and spontaneous conceptions, NIFT conceptions also had to be identified in order to be excluded. The flow diagram demonstrates that there were only 6 NIFT conceptions in the cohort, about 0.02%, which seems highly unlikely.
[Response] The NIFT was not regularly used at the six hospitals during the period between January 1st, 2009 and December 12th, 2010. This resulted in a very low proportion of NIFT in our database. We excluded these cases from our analyses.
Comment #3 Can the authors provide information on the number of IVF cycles and subsequent live births that occur in their geographical region to lend substance to their classification methods?
[Response] The number of IVF cycles was not routinely recorded. Sorry that we were unable to provide this information.
Comment #4 The authors identified >3% SMM cases due to a broad definition that includes PLTCs, MNMs, and CTIs. Some may be of the opinion that this definition is too non-specific. Please provide a subgroup analysis excluding severe preeclampsia and blood transfusion as SMM events -this will allow for identification of true SMM cases.
[Response] In our study, we adopted the WHO approach to defining SMM, which was widely recommended. We conducted a subgroup analysis excluding severe preeclampsia and blood transfusion from the SMM event set. The analysis showed consistent finding as below. Model 1 and Model 4 adjusted the following factors: maternal age, pre-pregnancy BMI, residence location, parity, smoking before pregnancy, IDA, HBV infection, hypertension, cardiac diseases, GDM, and gynecological diseases. Model 2 adjusted the following factors: maternal age, pre-pregnancy BMI, residence location, parity, and smoking before pregnancy. Model 3 adjusted the following factors: multiple gestations, maternal age, pre-pregnancy BMI, residence location, parity, smoking before pregnancy, IDA, HBV infection, hypertension, cardiac diseases, GDM, and gynecological diseases.
Comment #5 Please comment on how cesarean delivery plays a role in your analyses and whether cesarean delivery is a risk factor for SMM.
[Response] Cesarean delivery is associated with SMM. However, cesarean delivery is not a character at baseline, and is affected by multiple baseline variables, such as mode of conception, pre-pregnancy BMI and gestational co-morbidities. Therefore, we did not include this variable in our model. Table 5 should have a footnote that outlines the details of each model. The footnote should also include the confounding variables that are included in the models. The table should stand alone. In line with this, the report of models 1-4 in the results section of the abstract is a little confusing.
Comment #6
[Response] Thank you. We have added more details about the models to the footnote in table 5. We have revised the reporting of Models 1-4 in abstract. It now reads as below.
In total, 22,368 eligible pregnant women were included, among which 497 (2.22%) received IVF, and 776 developed SMM (incidence 34.69/1000 live births, 95%CI 32.29/1000-37.09/1000). Four multivariable logistic regression models were constructed. Model 1, without including the variable of multiple gestations, showed that IVF was associated with higher risk of SMM (adjusted odds ratio, aOR 1.54, 95%CI 1.03-2.29). Model 2, assessing the association between IVF and multiple gestations, showed that IVF was strongly associated with multiple gestations (aOR 14.75, ). Model 3, by adding the variable of multiple gestations to model 1, showed that IVF was not statistically associated with SMM (aOR 0.89, 95%CI 0.58-1.36), but multiple gestations was associated with higher risk of SMM (aOR 5.92, ). Model 4, investigating the association between IVF and SMM among singleton pregnancies, showed no statistically significant assocation (aOR 0.70, 95% CI 0.37-1.32). An additional analysis by adding the interaction term of IVF by gestations to model 3 showed no statistical significance of the interaction term (aOR 1.15, 95% CI 0.36 -3.68), confirming the absence of exposure-mediator interaction.
Comment #5 Discussion -This reviewer disagrees that there are no guidelines on number of embryos to transfer. In the United States, ASRM has clear guidelines on the number of embryos to transfer. This reviewer agrees that there is variability in terms of whether clinics adhere to the guidelines. Could the authors please comment on the practice of eSET in their geographical region and whether there are guidelines in China for this practice?
[Response] Apologies for the confusion. In our discussion, we cited the guideline about the number of embryos to transfer. However, as you suggested, the recommendations are not consistent. In the Chinese setting, no such guideline exists, and clinicians practice at their discretion and according to patient preference. We have added this to the discussion, as below.
In the Chinese setting, no clear recommendations are available. ART is not reimbursed by National Basic Medical Insurance in China. Patients who choose ART are typically wealthy, and prefer to transfer multiple embryos to improve the one-time success rate. Thus, despite the informed risk associated with the technology, multiple embryos transfer is commonly practiced. Reviewer: 3 Comment #1 As the authors point out, previous papers have focused on multiple gestations as an effect modifier between IVF and SMM. A strength of this paper is the mediation approach. However, the mediation analysis could be enriched. In particular, the authors use the Baron & Kenney (1986) method, which is a classic approach for mediation analysis and is appropriate if there is no exposure-mediator interaction. Additional analyses using modern approaches would be beneficial. For instance, it would be informative to assess what proportion of the total effect of IVF on SMM is due to multiple gestations using natural or controlled direct and indirect effect estimations; e.g. see any of the following references: If the analysis cannot be expanded, then the assumptions of no exposure-mediator interaction and of complete adjustment for relevant confounding variables (see comment #2 below) should be explicitly stated; and a brief discussion should be added to the limitations discussing the consequences of violations to these assumptions.
[Response] Many thanks for your helpful suggestions. In our revised analyses, we continue to use the Baron & Kenney (1986) method. However, we improved , as suggested, the analyses by testing for no exposure-mediator interaction (model 3 adding an interaction term, aOR 1.15, 95% CI 0.36 -3.68). The results showed that the exposure-mediator interaction was not statistically significant. It now reads as below.
In statistical analysis: Subsequently, by adding the variable of multiple gestations to model 1, we conducted the multivariable regression analysis (model 3). The coefficient of IVF in relation to SMM was recorded as β' and the coefficient of multiple gestations in relation to SMM was recorded as γ. In order to test for the assumption about the absence of exposure-mediator interaction, we additionally conducted an analysis by including an interaction term of IVF by multiple gestations in model 3.
In results: We conducted four multivariable logistic regression models. Model 1, without including the variable of multiple gestations, showed that IVF was associated with higher risk of SMM (adjusted odds ratio, aOR 1.54, 95%CI 1.03-2.29). Model 2, assessing the association between the use of IVF and multiple gestations, showed that IVF was strongly associated with multiple gestations (aOR 14.75, ). Model 3, by adding the variable of multiple gestations to model 1, showed that IVF was not statistically associated with SMM (aOR 0.89, 95%CI 0.58-1.36), but multiple gestations was associated with higher risk of SMM (aOR 5.92, ). An additional analysis by adding the interaction term of IVF by multiple gestations to Model 3 showed that the interaction term was not statistically significant (aOR 1.15, 95% CI 0.36 -3.68).
We also have included, in our analyses, potential confounders that were available to us. However, the retrospective nature of the study has limited us to include all potential confounders, including those that were not measured. We have added this limitation to the discussion section. It now reads as below.
Although we attempted to include all potential confounders in our analysis, some -such as uterine status and male factor -were difficult to measure and not available in our dataset. In addition, we were unable to control for other unmeasured confounders.
Comment #2 A directed acyclic graph (DAG) such as that below could also be helpful to include, with estimates of specific effects along the main pathways of interest to display the direct and indirect effect estimates. Even if such a graph is not included in the manuscript, it can be helpful to construct when thinking about what potential confounders need to be included. As stated in VanderWeele 2013, "For direct and indirect effects control needs to be made not only for confounders of the exposure-outcome relationship but also of the intermediate-outcome relationship and of the exposure-intermediate relationship. In addition, there should be no intermediate-outcome confounders that are themselves affected by the exposure."
[Response]Thanks for your thorough statistical guidance, which is helpful. For our paper, we aimed to make it readable for clinicians. On that ground, we decided not to present the graph. However, we found it quite useful for us to construct the analytic framework.
Comment #3 Model 4 (a subset on the singleton pregnancies) was included as a "supporting and exploratory analysis". Could you also include a model subset on multiple pregnancies evaluating the adjusted association between IVF and SMM among multiple pregnancies as a supporting and exploratory analysis? You do this for the unadjusted model; but not the adjusted model.
[Response] Because 78 SMM events occurred among 427 multiple gestations, we were concerned that the power of analyses would be highly limited, given the large of number of confounders for adjustment. We thus conducted a subgroup analysis in singleton pregnancies only.
Comment #4 In the conclusions, you note that "The results highlight the importance of transferring a limited number of embryos to reduce SMM". In a similar vein to the comments above, it would be helpful to expand the mediation analysis to yield results in clinically relevant and interpretable results -how many estimated SMM events would be avoided if IVF did not result in multiple gestations (e.g. if all cycles were restricted to elective single embryo transfers)?
[Response] We worked on several models, trying to produce the estimates you suggested. However, they did not seem to well address the issue. Is there any possibility that you offer a specific suggestion on the expansion of the mediation analysis? Thank you for your consideration.
Comment #5 Page 15, line 11: Among 22,368 eligible pregnancies extracted from medical charts and EMR database, was there really NO missing data on any of the variables you collected? That seems unlikely unless no missing data was part of the eligibility criteria. Please clarify.
[Response] In our analyses, we included patients whose data were complete for our analyses. We have supplemented the information in methods section, as below.
We checked for the completeness of data of all completed forms; if any missing data occurred, the forms were returned to investigators for data querying.
Minor Comments Comment #1 In the abstract, references to Model 1, Model 2, Model 3 and Model 4 are uninformative in that it is unclear what these labels imply for each model. A more descriptive explanation would be helpful. For instance, instead of "Model 1 showed that IVF was associated with …", say something like "In a model unadjusted for multiple gestations, IVF was associated with …".
[Response] Thanks, we have revised as suggested. It reads as below.
Four multivariable logistic regression models were constructed to examine the mediation effect of multiple gestations on the association between IVF and SMM. Model 1, without including the variable of multiple gestations, showed that IVF was associated with higher risk of SMM (adjusted odds ratio, aOR 1.54, 95%CI 1.03-2.29). Model 2, assessing the association between IVF and multiple gestations, showed that IVF was strongly associated with multiple gestations (aOR 14.75, ). Model 3, by adding the variable of multiple gestations to model 1, showed that IVF was not statistically associated with SMM (aOR 0.89, 95%CI 0.58-1.36), but multiple gestations was associated with higher risk of SMM (aOR 5.92, ). Model 4, investigating the association between IVF and SMM among singleton pregnancies, showed no statistically significant assocation (aOR 0.70, 95% CI 0.37-1.32). An additional analysis by adding the interaction term of IVF by gestations to model 3 showed no statistical significance of the interaction term (aOR 1.15, 95% CI 0.36 -3.68, confirming the absence of exposure-mediator interaction.
Comment #2 In the abstract conclusions, "the impact of IVF of SMM was mediated…" (not "medicated")
[Response] We have corrected the typing errors throughout the manuscript.
Comment #3 Page 5, line 6 -"transplant" should be "transfer"
[Response] We have changed the wording. Comment #4 Page 10, "SMM definition and measurement" section --There are so many acronyms in this section, it becomes confusing. It would be clearer for the reader if MNM, SMC, and CTI were replaced with "maternal near miss", "severe maternal complications" and "critical interventions", respectively. Similarly, on page 14 (second paragraph of results).
[Response] We have revised the wording, as suggested. [Response] The risk of SMM was generally similar. In fact, the practice of IVF at these six hospitals was standardized -the academic medical center offers practice guidance for the other five hospitals. We believe that the current analyses are robust, even if multi-level analyses are not undertaken.
Comment #7 Page 15, lines 43, 48, 53: The p-value is unnecessary to display. The 95% confidence interval offers the same information as a p-value and is more informative.
[Response] We have removed the p value.
Comment #8Page 16, lines 16, 21, 26, 43: P-values can be removed. Confidence intervals are the more informative measure here, and they are already being presented.
[Response] We have removed the p values.
Comment #9 Page 19, line 16: I wouldn't say that the interaction approach is "undesirable"; rather, it is a different approach that leads to different information. Just because multiple gestations is a consequence of IVF does not mean interaction analysis is not appropriate; indeed, one needs to consider whether there is exposure-mediator interaction in order to determine the appropriate mediation approach.
[Response] We have revised the discussion, as below.
In assessing the association between the use of IVF and SMM, previous studies typically considered multiple gestations as an effect modifier (i.e. by conducting subgroup analysis to examine the association between multiple gestations versus singleton pregnancy populations). However, either multiple gestations or singleton pregnancy was a consequence of the IVF. Thus, an appropriate interpretation is that the resulting multiple gestations, due to the use of IVF, may determine the undesirable effect on SMM. As a result, our analyses have supported this hypothesis.
Comment #10 Page 19, line 30: This is strong language; "our analyses support this hypothesis" is more appropriate than "confirmed".
[Response] Thank you. We have revised the wording. The description of the methods makes it seem like these patients were prospectively followed within a study protocol, however it is simply usual clinical care and a retrospective chart review. This needs to be made more clear. In fact the WHO criteria for SMM remains similar to that by Belanoff et al, and others who simply use ICD codes for all that is captured in the WHO version. The authors do not comment on the limitation of ICU admission as an independent indicator -are some of these admissions for less than 24 hours and for monitoring only? This practice might vary by site. I still do not understand including a center that does 300 deliveries per year -is this a center that can be compared to the others? Probably should be removed as an outlier. The authors did not report events per center in this version. The authors incompletely discuss limitations in the discussion. They seem to indicate that the reason they did not find a high risk of SMM among singletons is because they looked at IVF only while others have combined other treatments -in fact, wouldn't you expect that those other lower-risk treatments would dilute rather than inflate the effect? How would they explain a LOWER risk? (counter intuitive) Martin and Belanoff each reported outcomes in singletons vs multiples separately (i.e. did not simply adjust for it) and found higher risk in both groups. Belanoff compared to subfertile while the authors of this manuscript did not. Thus, the authors could not account for confounding by indication. Insufficient exploration for why their study is dramatically different than both of these well done large population based studies.
VERSION 2 -REVIEW
REVIEWER
Differences in populations can also account for these differences in finding, which is not discussed. There is no assessment of type of IVF (donor/autologous, fresh/frozen). Also, the authors use 'mediation effect' and 'effect modification' interchangeably but these terms are not quite interchangeable. Effect modification should be evaluated on the additive scale (using relative excess risk index) and multiplicative scales. They should not confuse these terms. The authors still did not include a power calculation or describe the uncertainty of their result.
Erica Wang
Cedars-Sinai Medical Center REVIEW RETURNED 14-Aug-2018
GENERAL COMMENTS
The authors have overall addressed my comments. I would recommend that the subgroup analysis excluding severe preeclampsia and blood transfusion from the SMM definition be mentioned in the results section. o Page 12, Line 26: "significantly statistical" should be "statistically significant" o Page 3, Line 11 (Abstract): "higer" should be "higher" o Page 12, Line 40: "medication effect" should be "mediation effect" o Page 18, Lines 31-38: "of total events" is repeated twice. Remove "as a matter of fact". This is not a complete list of errors. The manuscript should be thoroughly edited in order to attain the standard of written English acceptable for publication.
2. Page 19, Lines 1-14: I agree with the authors that discrepancies in the overall results between this study and previous studies could be due to differences in defining the outcome (SMM) , differences in defining the exposure (IVF vs. any assisted reproductive technology), and/or differences in confounder adjustment in multivariable models. However, the question specifically addressing IDA and HBV adjustment can easily be assessed. The authors note, "Due to high prevalence of IDA and HBV infection in Chinese population, adjustment for these two confounders may alter the association between IVF and SMM." It should be easy to run an adjusted model leaving out these two variables. How do the relevant coefficients for a model that adjusts for all confounders except IDA and HBV change from the fully adjusted model? If the results change substantially (and in the direction which would support your claim above), then this should be included in the paper.
Otherwise, this example as a possible explanation for differences in study results should be removed.
VERSION 2 -AUTHOR RESPONSE
Reviewer: 1 Comment #2 The authors have made some positive changes but there are still outstanding issues that remain unresolved. English language still requires proof reading and editing. IVF is in vitro fertilization.
[Response] Thank you. We have carefully edited the language throughout the manuscript, and hope that the current version meets the requirement of the journal.
Comment #3 Do not abbreviate case report form. Mode of conception not model of conception, etc. There are several other grammatical issues.
[Response] Thank you for your suggestion. We have carefully checked for the grammatical errors throughout the manuscript, and corrected those errors.
Comment #4 The description of the methods makes it seem like these patients were prospectively followed within a study protocol, however it is simply usual clinical care and a retrospective chart review. This needs to be made more clear.
[Response] Thank you for your note. We have revised the methods section to make the description clearer, as below. 
We retrospectively collected the information from medical charts or EMR databases
Comment #7 I still do not understand including a center that does 300 deliveries per year -is this a center that can be compared to the others? Probably should be removed as an outlier. The authors did not report events per center in this version
[Response] The other reviewer had a similar question, and suggested conducting a sensitivity analysis. In response to the legitimate recommendation, we have conducted a sensitivity analysis by removing this center (Supplementary table 2) . The findings were similar. We also reported the events per center in the results.
Comment #8 The authors incompletely discuss limitations in the discussion [Response]
We have expanded our discussion about limitations, now read as below.
Our study also has a few limitations. Comment #10 Martin and Belanoff each reported outcomes in singletons vs multiples separately (i.e. did not simply adjust for it) and found higher risk in both groups. Belanoff compared to subfertile while the authors of this manuscript did not. Thus, the authors could not account for confounding by indication. Insufficient exploration for why their study is dramatically different than both of these well done large population based studies. Differences in populations can also account for these differences in finding, which is not discussed.
[Response] Thank you for the note. We have added more discussions about the reasons for the differences. They read as below. [Response] We were unable to collect this information, and have added this to the limitation. Now it reads as below.
We were also unable to assess the associations between types of IVF (donor versus autologous, fresh versus frozen) and SMM, as such information was unavailable.
Comment #12 Also, the authors use 'mediation effect' and 'effect modification' interchangeably but these terms are not quite interchangeable. Effect modification should be evaluated on the additive scale (using relative excess risk index) and multiplicative scales. They should not confuse these terms.
[Response] Apologies for the confusion. We have corrected the wording throughout the manuscript.
Comment #13 The authors still did not include a power calculation or describe the uncertainty of their result.
[Response] Thanks for your suggestion. However, we don't agree that a post hoc power calculation could add important information. This study was a retrospective cohort study, in which we included all patients in our analyses. The data and resulting findings (i.e. point estimate and confidence intervals) would provide all that the users need. We now have added comments on the uncertainty of results to the discussion. Reviewer: 2 Comment #1 The authors have overall addressed my comments. I would recommend that the subgroup analysis excluding severe preeclampsia and blood transfusion from the SMM definition be mentioned in the results section.
[Response] Thank you. We now have added a sensitivity analysis by excluding severe preeclampsia and blood transfusion from the SMM event set in Supplementary Table 1 . The findings were similar. Comment #3 The writing is improved, but further editing for language is still needed.
Comment #2
[Response] Thanks for your comments. We have carefully revised the manuscript and hope that the current version meets the requirement of the journal. [Response] Many thanks for you notes. We have thoroughly checked for and corrected grammatical errors throughout the manuscript. We also have revised the wording to improve the quality of language. We hope that the current version meets the requirement of the journal.
Comment #2 Page 19, Lines 1-14: I agree with the authors that discrepancies in the overall results between this study and previous studies could be due to differences in defining the outcome (SMM) , differences in defining the exposure (IVF vs. any assisted reproductive technology), and/or differences in confounder adjustment in multivariable models. However, the question specifically addressing IDA and HBV adjustment can easily be assessed. The authors note, "Due to high prevalence of IDA and HBV infection in Chinese population, adjustment for these two confounders may alter the association between IVF and SMM." It should be easy to run an adjusted model leaving out these two variables. How do the relevant coefficients for a model that adjusts for all confounders except IDA and HBV change from the fully adjusted model? If the results change substantially (and in the direction which would support your claim above), then this should be included in the paper. Otherwise, this example as a possible explanation for differences in study results should be removed.
[Response] Thank you. We have re-estimated the association by removing the variables of IDA and HBV from our model. The direction of results remained unchanged. We have removed that claim, as suggested.
VERSION 3 -REVIEW
REVIEWER
Natalie Dayan
McGill University Health Centre, Canada REVIEW RETURNED 01-Nov-2018
GENERAL COMMENTS
The authors have adequately addressed my concerns. I ask that they avoid the use effect modification or effect measure modification as they make a point of distinguishing this from mediation analysis. A biostatistician with expertise in mediation analysis must review this paper prior to consideration for publication. The authors have adequately addressed my concerns. I ask that they avoid the use effect modification or effect measure modification as they make a point of distinguishing this from mediation analysis.
A biostatistician with expertise in mediation analysis must review this paper prior to consideration for publication.
[Response] Thank you for your review. We have revised the manuscript according to your suggestion. We also have carefully checked the statistical parts to make sure the analysis is appropriate.
Reviewers' Comments to Author:
Comment #3 Do not abbreviate case report form. Mode of conception not model of conception, etc. There are several other grammatical issues.
[Response] Thank you for your note. We have revised the methods section to make the description clearer, as below. Comment #10 Martin and Belanoff each reported outcomes in singletons vs multiples separately (i.e. did not simply adjust for it) and found higher risk in both groups. Belanoff compared to subfertile while the authors of this manuscript did not. Thus, the authors could not account for confounding by indication. Insufficient exploration for why their study is dramatically different than both of these well done large population based studies. Differences in populations can also account for these differences in finding, which is not discussed.
[Response] Thank you for the note. We have added more discussions about the reasons for the differences. They read as below. 
